The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...

According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.

Prostate-Specific Antigen (PSA) and Magnetic Resonance Imaging (MRI) are widely used in the diagnosis of prostate cancer (PCa), but relatively inaccurate results may affect diagnosis and treatment.

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

Prostate cancer affects 1 in 8 men, but experts say it’s highly treatable when caught early. A survivor shares how PSA ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Liquid biopsies look for cancer signals in the blood, and while the tests for early ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

Millions of men face a decision about whether to be screened for prostate cancer. National guidelines say that decision ...